An experienced partner with deep domain knowledge is key for developing robust, well-designed systems. Learn more as experts discuss the benefits of using integrated systems for sophisticated drug device combination products with multiple device subsystems, and the crucial role a partner can play as systems integrator.
Developing an effective drug-device combination product for self-administered biologics is a complex process. It requires critical decisions during delivery system selection, and making the right choices at an early stage can reduce risks. A well-executed strategy will help support integration with manufacturing operations and successful drug delivery.
The biosimilar development market is becoming increasingly competitive, putting first-to-market companies at a key advantage. A partner that can help sponsors manage costs will be essential to achieve commercial success. Discover how to de-risk the launch process by choosing a suitable autoinjector technology and partner.
Gain flexibility to serve design space requirements for continuous, episodic, or delayed subcutaneous delivery of volumes up to 3 mL for up to three-day wear. The system is designed to be programmable, allowing for convenient medication delivery outside of acute care settings.
